Association between antidepressant drugs and falls in older adults: A mediation analysis in the World Health Organization's pharmacovigilance database
Abstract
OBJECTIVES: The objective is to investigate the association between antidepressant drugs intake and falls reporting, as well as the potential mediators in-between, in older adults. METHODS: In VigiBase®, the World Health Organization's pharmacovigilance database, we performed a disproportionality analysis to probe the putative associations between each antidepressant drugs class (non-selective monoamine reuptake inhibitors [NSMRIs], selective serotonin reuptake inhibitors [SSRIs], serotonin-norepinephrine reuptake inhibitors [SNRIs], alpha-2-adrenergic receptor antagonists, and "other antidepressants") and reports of falls in people aged 65 and over (NCT05628467). The reporting odds ratios and their 95% confidence interval were derived from logistic regression models with adjustment for confounders. We studied the falls-inducing mechanisms (delirium, hyponatremia, hypotension) by using causal mediation analyses and by using a disproportionality analysis for the co-occurrence of falls and these events. RESULTS: Our main analysis included 86,200 cases of falls reporting in older adults (of which 57% were 75 and over). A significant association was found between falls and every antidepressant drugs class, except for NSMRIs. According to causal mediation analysis, a direct effect on the falls reports was shown for alpha-2-adrenergic receptor antagonists and for "other antidepressants". According to the co-reports analyses, all antidepressant drugs classes except SNRIs were associated with the co-event fall-delirium; SSRIs, alpha-2-adrenergic receptor antagonists, and "other antidepressants" with fall-hypotension; all antidepressant drugs classes except NSMRIs with fall-hyponatremia. CONCLUSIONS: In multivariate disproportionality analyses, all antidepressant drugs classes were associated with signals of disproportionate reporting of falls in older adults, except for NSMRIs. In mediation analyses, a direct effect on the falls reports was only found for alpha-2-adrenergic receptor antagonists. Single-mediators based models seem insufficient to explain the diversity of clinical settings resulting in falls. These findings underline the necessity of a comprehensive analysis of all clinical and pharmacological features in older falling adults treated with antidepressant drugs.
Related
- Potential association between IL-12/23, IL-23, and IL-17 inhibitors and skin cancer: a pharmacovigilance study based on the FAERS database
- Associations between early antidepressant exposure, affective states, and subjective sleep quality among euthymic depressive-onset bipolar patients: a cross-sectional parallel mediation analysis
- Safety Profile of Tirzepatide in Real‐World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database
- Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database
- Safety of eribulin: A real-world study based on a pharmacovigilance database
BibTeX
@article{minoc2026association,
title = {{Association between antidepressant drugs and falls in older adults: A mediation analysis in the World Health Organization's pharmacovigilance database}},
author = {Elise-Marie Minoc and Cédric Villain and Basile Chrétien and Soumia Benbrika and Marie Heraudeau and Claire Lafont and Clémence Béchade and Thierry Lobbedez and Véronique Lelong-Boulouard and Charles Dolladille},
journal = {Therapies},
year = {2026},
month = sep,
doi = {10.1016/j.therap.2025.01.004},
url = {https://hal.science/hal-05746268v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Association between antidepressant drugs and falls in older adults: A mediation analysis in the World Health Organization's pharmacovigilance database
AU - Elise-Marie Minoc
AU - Cédric Villain
AU - Basile Chrétien
AU - Soumia Benbrika
AU - Marie Heraudeau
AU - Claire Lafont
AU - Clémence Béchade
AU - Thierry Lobbedez
AU - Véronique Lelong-Boulouard
AU - Charles Dolladille
PY - 2026
DA - 2026/09/11
JO - Therapies
DO - 10.1016/j.therap.2025.01.004
UR - https://hal.science/hal-05746268v1
AB - OBJECTIVES: The objective is to investigate the association between antidepressant drugs intake and falls reporting, as well as the potential mediators in-between, in older adults. METHODS: In VigiBase®, the World Health Organization's pharmacovigilance database, we performed a disproportionality analysis to probe the putative associations between each antidepressant drugs class (non-selective monoamine reuptake inhibitors [NSMRIs], selective serotonin reuptake inhibitors [SSRIs], serotonin-norepinephrine reuptake inhibitors [SNRIs], alpha-2-adrenergic receptor antagonists, and "other antidepressants") and reports of falls in people aged 65 and over (NCT05628467). The reporting odds ratios and their 95% confidence interval were derived from logistic regression models with adjustment for confounders. We studied the falls-inducing mechanisms (delirium, hyponatremia, hypotension) by using causal mediation analyses and by using a disproportionality analysis for the co-occurrence of falls and these events. RESULTS: Our main analysis included 86,200 cases of falls reporting in older adults (of which 57% were 75 and over). A significant association was found between falls and every antidepressant drugs class, except for NSMRIs. According to causal mediation analysis, a direct effect on the falls reports was shown for alpha-2-adrenergic receptor antagonists and for "other antidepressants". According to the co-reports analyses, all antidepressant drugs classes except SNRIs were associated with the co-event fall-delirium; SSRIs, alpha-2-adrenergic receptor antagonists, and "other antidepressants" with fall-hypotension; all antidepressant drugs classes except NSMRIs with fall-hyponatremia. CONCLUSIONS: In multivariate disproportionality analyses, all antidepressant drugs classes were associated with signals of disproportionate reporting of falls in older adults, except for NSMRIs. In mediation analyses, a direct effect on the falls reports was only found for alpha-2-adrenergic receptor antagonists. Single-mediators based models seem insufficient to explain the diversity of clinical settings resulting in falls. These findings underline the necessity of a comprehensive analysis of all clinical and pharmacological features in older falling adults treated with antidepressant drugs.
SN - 0040-5957
SN - 1958-5578
ER -